BRIEF published on 12/05/2024 at 13:05, 11 months 30 days ago SideChannel Reports Financial Results for Fiscal Year 2024 Financial Results Revenue Growth Cybersecurity Fiscal Year 2024 SideChannel
BRIEF published on 12/05/2024 at 13:05, 11 months 30 days ago SideChannel publie ses résultats financiers pour l'exercice 2024 Résultats Financiers Cybersécurité Exercice 2024 Croissance Des Revenus Canal Latéral
PRESS RELEASE published on 12/05/2024 at 13:00, 11 months 30 days ago SideChannel Achieves Full Year Cash Provided by Operations SideChannel, Inc. announces fiscal year 2024 financial results with revenue growth of 12.8% to $7.4 million. Management focuses on sustainable cash flow and Enclave revenue growth for 2025 Financial Results Revenue Growth Cybersecurity Services SideChannel Inc. Enclave Revenue
PRESS RELEASE published on 05/09/2023 at 13:30, 2 years 6 months ago SideChannel Strategy Validated by Revenue Growth of 30.9% Year-over-year in Second Quarter 2023
Published on 12/05/2025 at 02:35, 4 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 21 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 6 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
